Board Prep Course Recordings
Ensure you're board-exam ready with ACP's 2023 Internal Medicine Board Review Course Recordings—a multimedia, self-study program that delivers multiple study tools for you to review and reinforce the content likely to be questioned on the exam.
View lectures in any order and as often as you like to solidify your knowledge. These on-demand multimedia sessions include 39+ hours of content and more than 250 board-style questions. ACP’s Board Review Course Recordings Package breaks the lectures into targeted, short single-question segments, so you can create a custom study schedule.
Copyright 2023 ¹Ü¼ÒÆÅÐÄË®ÂÛ̳. All Rights Reserved.
CME/MOC:
Up to 39.25
AMA PRA Category 1 Credits ™ and MOC Points
Expires September 01, 2025
active
Cost:
Discounted to Members
Format:
Video Recordings
Product:
Board Prep Course Recordings
ACP's board prep recordings are ideal for those who enjoy watching lectures at their own pace. Videos were recorded live from ACP’s Internal Medicine Board Review Course or MOC Exam Prep Course. Combining live courses and the course recordings are an effective option for a blended learning approach. Stream the sessions to your device or download for offline study.
Faculty Disclosures
The following individuals have relevant financial relationships with ineligible companies, as listed. No other individuals in control of content for this activity have any relevant financial relationships. All relevant financial relationships have been mitigated.
Rashmi Chugh, MD - Grant/Contract Consultant: AADi, Advenchen, Astrazenica Pharmaceuticals LP, Ayala, Cogent Therapautics LLC, Cornerstone Pharmaceuticals, Deciphera Pharmaceuticals Inc, Epizyme Inc, GlaxoSmithKline, Incyte Corp, Ipsen Biopharmaceuticals, Janssen Biotech, Jazz Pharmaceuticals, Medivation Inc, Mundipharma, Novartis, Pfizer, Plexxikon Inc., PTC Therapeutics, Qilu Pugent Sound, Springworks
Laura Mariani, MD - Consultant: Boehringer Ingelheim, Calliditas Therapeutics, Chinook Therapeutics, Reata Pharmaceuticals, Travere Therapeutics, Inc.
Dejan Micic, MD - Consultant: Napo Pharmaceuticals Inc, Takeda Pharmaceutical Co.
Frank Wang, MD - Research Grant Support: ET Browne Company, Galderma Laboratories L.P.
Andrew Bomback, MD, MPH - Consultantship: Chemocentrys, Novartis, Retrophin, Inc.
Houman Homayoun, MD - Consultantship: Medtronic USA, Inc.
Bonita S. Libman, MD, FACP, FACR - Contracts: AbbVie, Novartis
Tabassum Salam, MD, MBA, FACP - Consultantship: Johnson & Johnson
Accreditation Statement
The ¹Ü¼ÒÆÅÐÄË®ÂÛ̳ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The ¹Ü¼ÒÆÅÐÄË®ÂÛ̳ designates this enduring material for a maximum of 39.25 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 39.25 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.